Navigation Links
CSHL scientists clarify editing error underlying genetic neurodegenerative disease
Date:1/28/2009

Two molecular biologists at Cold Spring Harbor Laboratory have uncovered important new details about how a gene mutation causes a cellular editing error that results in a devastating disease called pontocerebellar hypoplasia (PCH). The new findings were published online, ahead of print, on January 25th in the journal Nature Structural and Molecular Biology.

Typically striking during early childhood, PCH is characterized by the slow wasting away of certain parts of the brain, resulting in abnormal brain function and cognitive impairment characteristic of mental retardation. Although scientists have known about the gene mutation that causes the disease, they haven't been able to explain why the mutation causes a defect in an essential cellular function called RNA splicing.

RNA splicing is an essential step in the process in cell nuclei whereby instructions encoded in DNA are transcribed to RNA copies, which subsequently leave the nucleus to serve as templates for the cellular machinery to manufacture protein molecules. The RNA intermediaries (called "messengers"), in order to function properly in this role, are typically "edited" by special enzymes, which perform a procedure analogous to the editing of frames in a film, where unnecessary frames are left out of the final version.

An 'atypical' splice site

The new discovery stems from a program of research by Professor Adrian Krainer, Ph.D., and members of his lab at CSHL, to understand how cells process the information encoded in genes. For reasons that remain poorly understood, the raw or unedited RNA copy of DNA includes excess RNA segments called introns that need to be edited out in order for the RNA's message to be functional. Once the introns are removed, the remaining segments -- called exons -- are pasted together, forming a mature messenger RNA transcript.

In an unedited RNA molecule, the boundaries between an intron and its two flanking exons
'/>"/>

Contact: Hema Bashyam
bashyam@cshl.edu
516-367-6822
Cold Spring Harbor Laboratory
Source:Eurekalert

Page: 1 2 3 4

Related biology news :

1. Weizmann Institute scientists discover how cancer cells survive a chemotherapy drug
2. Substantial work ahead for water issues, say scientists at ACS Final Report briefing
3. CSHL scientists find a new class of small RNAs and define its function
4. Scientists uncover new genetic variations linked to psoriasis
5. 3 new informatics pilot projects to aid clinical and translational scientists nationwide
6. Scientists identify bacteria that increase plant growth
7. Scientists use lasers to measure changes to tropical forests
8. Scientists unlock possible aging secret in genetically altered fruit fly
9. Jefferson scientists discover a key protein regulator of inflammation and cell death
10. MUHC and McGill scientists explain genetic disease first discovered in Quebec 24 years ago
11. Scientists uncover evolutionary keys to common birth disorders

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... NEW YORK (November 24, 2009) -- The Wildli...port revealing that the last remaining population ...ly due to the rising tide of poaching and habitat ...p inform Russian officials of what needs to be don...biggest cat. , The report was relea...
(Date:11/23/2009)...TINew research presents strong evidence that the "... outdoor traffic-related pollution and indoor endo...e or the other exposure alone. , Environmental... (UC) College of Medicine have shown that children...rticles and indoor endotoxin during early life are...
(Date:11/23/2009)...Calif. -- More than 160 participants gathered this...ck FUTURES INITIATIVE conference. This year,s topi...s, engineers, and medical researchers to explore t...ounding the emerging field of synthetic biology. ,...gy at Princeton University and this year,s confere...
Breaking Biology News(10 mins):Report shows dramatic decline in Siberian tigers 2Exposure to both traffic, indoor pollutants puts some kids at higher risk for asthma later 2Synthetic biology offers new opportunities for interdisciplinary collaboration 2Derma Sciences Files S 1 Registration Statement 6296 1Derma Sciences Files S 1 Registration Statement 6296 2Derma Sciences Files S 1 Registration Statement 6296 3Pharmacists Work with Congress to Address PBM Abuses 6292 1Pharmacists Work with Congress to Address PBM Abuses 6292 2Migraine Increases Likelihood of Stroke 61426 1Migraine Increases Likelihood of Stroke 61426 2
...ction of a protein called vasostatin may prove a p...ggests research published ahead of print in Gut. ,...ancer deaths in the developed world, and is extrem...ts are still alive five years after diagnosis, a s... three decades. , Currently, the only viable trea...
...nts, tiny metal scaffolds inserted into blood vess...s with heart disease, by reducing the risk of infl...new technique, using a compound that binds in an e...ve potential uses in other areas of medicine that ...quently treat heart disease patients now by using ...
... Genome-Wide RNAi Global Initiative, an alliance o...rmed to speed scientific and medical discoveries t...nitiative is sponsored by Dharmacon, Inc. , manuf...ibrary, or compilation of short, interfering ribon...determine when individual genes are functioning. I...
Other Biology News:Jefferson researchers find nanoparticle shows promise in reducing radiation side effects 2Bare metal stents deliver gene therapy to heart vessels with less inflammation in animal studies 2Yale participates in global human genome initiative 2
(Date:11/24/2009)...e-FirstCall/--IES(Nasdaq: IESC ),aleadingnationalp...icesforthecommercial,industrialandresidentialmarke...beenawardedacontractfromManhattanTorconJVtoinstall...4)replacementfacilityattheU.S.ArmyMedicalResearchI...kinFrederick,Md. ,, ThenewUSAMRIIDreplacementfa...
(Date:11/24/2009)...io,Nov.24/PRNewswire-FirstCall/--DowAgroSciencesCa...eds,adivisionofThompsonsLimitedofBlenheim,Ontario....iences,currentseedsbusinessasthecompanyanticipates...roSciencesHerbicideTolerantTraitTechnologyincornin...e. ,, "Thisacquisitionbringstogethertwostrongpr...
(Date:11/24/2009)...er24/PRNewswire-FirstCall/--deCODE,genetics,Inc.(N...firstday"motionsbytheU.S.BankruptcyCourtfortheDist...ekfiledavoluntarypetitionfor,reliefunderChapter11o...urt. , TheordersissuedbytheBankruptcyCourtall...heChapter11proceedings.Inparticular,the,companyrec...
(Date:11/24/2009)...e/--BlueMarbleEnergyCorp.announcedtodaythatthecomp...erecentlyawarded$2millionbyWashingtonState,sCommun...licpartnershiptoconstructthestate,sfirstspecialtyb...isinvestmentwillsignificantlyspeedthedevelopmentof...ty,"saidBlueMarbleEnergyCEOKellyOgilvie."Wearegrat...
Breaking Biology Technology:Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2
...for Animals to be Produced in Changzhou Hi-Tech ...OU, China, April 25 /Xinhua-PRNewswire/ -- A proje...s was recently launched in,Changzhou National High...s,is a new product developed by a team of leading ... first time for China will produce this kind of,hi...
... CV Therapeutics,Inc. (Nasdaq: CVTX ) today repo... March 31, 2008., For the quarter ended March 31,...llion, or $0.53 per share. This compares to a net ... prior quarter ended December 31, 2007,and $55.1 m...n 2007., For the quarter ended March 31, 2008, th...
...ts and Collaborators Publish Study in Science, DR...the,leading developer of RAFT intervention therape...in Science demonstrating a potential novel strateg...other diseases by targeting,discrete sub-compartme...ted,by JADO scientists together with several acade...
Other Biology Technology:Leading Overseas Scientists Establish High-Tech Bio-Pharmaceutical Enterprise in Changzhou 2Leading Overseas Scientists Establish High-Tech Bio-Pharmaceutical Enterprise in Changzhou 3CV Therapeutics Reports 2008 First Quarter Financial Results 2CV Therapeutics Reports 2008 First Quarter Financial Results 3CV Therapeutics Reports 2008 First Quarter Financial Results 4CV Therapeutics Reports 2008 First Quarter Financial Results 5Novel Approach to Treat Alzheimer's and Other Diseases Offered by Targeting Cell Membrane RAFTS 2Novel Approach to Treat Alzheimer's and Other Diseases Offered by Targeting Cell Membrane RAFTS 3Novel Approach to Treat Alzheimer's and Other Diseases Offered by Targeting Cell Membrane RAFTS 4
Rattler Plating Beads from Zymo Research
di-3-ANEPPDHQ from Molecular Probes (Invitrogen)
TEMPLIPHI HT SEQ AMPL KIT from GE Healthcare, formerly Amersham Biosciences
RayBio Human Inflammation Antibody Array III & 3.1 Service from Raybiotech, Inc.
Biology Products: